About: NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $20.80 (-0.62%)
NAMS NASDAQ NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Company N.V. Ordinary Shares share price
NAMS price activity
Last Price
$19.950
Change (24hr)
-0.98 USD (4.68%)
Volume
59.77K
Volume (4w avg)
-
Open
$20.77
Day Range
$19.84 - $20.77
Previous Close
$20.93
Last Trade
05 Nov, 3:10 pm GMT+0
Delayed
05 Nov, 3:10 pm GMT+0
NAMS price performance
Delayed
05 Nov, 3:10 pm GMT+0
NAMS details
NAMS Market Signals